← Evidence map

ArticleVaccines2023

Suitability of Polymyxin B as a Mucosal Adjuvant for Intranasal Influenza and COVID-19 Vaccines.

Naoto Yoshino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 38006059